Search Results - "Lin, Yuehui"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    A study on the formula of fundamental period of high-rise shear wall structures based on ambient vibration testing by Yang, Zhou, Jian, Meng, Yuehui, Lin, Zhengxin, Qi, Fu, He

    Published in Structures (Oxford) (01-06-2024)
    “…The dynamic performance test was conducted on 50 high-rise shear wall structures with heights ranging from 30 to 80 m in the high-risk seismic region of…”
    Get full text
    Journal Article
  5. 5

    Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy by An, Lihong, Lin, Yuehui, Deng, Biping, Yin, Zhichao, Zhao, Defeng, Ling, Zhuojun, Wu, Tong, Zhao, Yongqiang, Chang, Alex H, Tong, Chunrong, Liu, Shuangyou

    Published in BMC cancer (12-04-2022)
    “…For CD19-positive relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL) after treatment with murine CD19 (mCD19) CAR-T, the reinfusion of mCD19…”
    Get full text
    Journal Article
  6. 6

    Case report: Plasma cell leukemia secondary to multiple myeloma successfully treated with anti-BCMA CAR-T cell therapy by Deng, Jingjing, Lin, Yuehui, Zhao, Defeng, Tong, Chunrong, Chang, Alex H., Chen, Wenming, Gao, Wen

    Published in Frontiers in oncology (21-09-2022)
    “…Chimeric antigen receptor (CAR)-T cell therapy provides an effective salvage treatment for relapsed/refractory multiple myeloma (RRMM) patients. End-stage RRMM…”
    Get full text
    Journal Article
  7. 7

    CAR‐T therapy as a consolidation in remission B‐ALL patients with poor prognosis by Yin, Zhichao, Lin, Yuehui, Liu, Dan, Tong, Chunrong, Liu, Shuangyou

    Published in Cancer reports (01-10-2022)
    “…Background To date, almost all studies regarding chimeric antigen receptor (CAR)‐T cell therapy for B‐cell acute lymphoblastic leukemia (B‐ALL) were performed…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    The Efficacy and Safety of Olverembatinib Combined with Monoclonal Antibodies As Salvage Therapy for RR B ALL with ABL1 Fusion Gene Positive by Lin, Yuehui, Wu, Tong, Liu, Dan, Tong, Chunrong

    Published in Blood (02-11-2023)
    “…Background: B cell acute Lymphoblastic Leukemia (B ALL) with ABL1 fusion gene(FG) positive(ABL1+B ALL) is classified as Ph or Ph like ALL and has a poor…”
    Get full text
    Journal Article
  12. 12

    Clinical Implications of Germline Predisposition Gene Variants in Patients with Refractory or Relapsed B Acute Lymphoblastic Leukemia by Defeng, Zhao, Wu, Tong, Tong, Chunrong, Yuehui, Lin, Zheng, Qinlong

    Published in Blood (02-11-2023)
    “…Objectives:Gene variants are important factors in prognosis of the patients with hematological malignancies. In current study, our team investigate the…”
    Get full text
    Journal Article
  13. 13

    Combination of CD19 and CD22 CAR‐T cell therapy in relapsed B‐cell acute lymphoblastic leukemia after allogeneic transplantation by Liu, Shuangyou, Deng, Biping, Yin, Zhichao, Lin, Yuehui, An, Lihong, Liu, Dan, Pan, Jing, Yu, Xinjian, Chen, Bingzhen, Wu, Tong, Chang, Alex H., Tong, Chunrong

    Published in American journal of hematology (01-06-2021)
    “…The prognosis of relapsed acute lymphoblastic leukemia (ALL) after allogeneic transplantation is dismal when treated with conventional approaches. While…”
    Get full text
    Journal Article
  14. 14

    A Novel t(9;22;11) Translocation Variant Involving 11q23 in a Patient with Chronic Myeloid Leukemia by Yuehui, Lin, Zheng, Qinglong, Wu, Tong, LIU, DAN

    Published in Blood (05-11-2020)
    “…Background:The progression of Philadelphia chromosome positive chronic myeloid leukemia (CML) is frequently accompanied by cytogenetic evolution, commonly…”
    Get full text
    Journal Article
  15. 15

    Sequential CD19- and CD22-CART Cell Therapies for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation by Liu, Shuangyou, Deng, Biping, Lin, Yuehui, Yin, Zhichao, Pan, Jing, Wu, Tong, Gao, Zhiyong, Song, Yanzhi, Zhao, Yongqiang, Tong, Chunrong

    Published in Blood (29-11-2018)
    “…With traditional therapies, the prognosis of relapsed acute lymphoblastic leukemia (ALL) after allogeneic hematopoietic stem cell transplantation (allo-HSCT)…”
    Get full text
    Journal Article
  16. 16

    Corticosteroids Do Not Influence the Efficacy and Kinetics of CAR-T Cells for B-Cell Acute Lymphoblastic Leukemia by Liu, Shuangyou, Deng, Biping, PAN, Jing, Yin, Zhichao, Lin, Yuehui, Ling, Zhuojun, Wu, Tong, Gao, Zhiyong, Song, Yanzhi, Zhao, Yongqiang, Tong, Chunrong

    Published in Blood (13-11-2019)
    “…▪ Cytokine release syndrome (CRS) is the most prominent and potentially life-threatening toxicity caused by chimeric antigen receptor (CAR) T cell therapy,…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20